“To overcome cancer, you need to have a community,” said Thomas J. Lynch Jr., MD, president and director of Fred Hutch and holder of the Raisbeck Endowed Chair, to the crowd of Obliteriders and guests on Friday night. With more than 6,200 people registered, and more than 800 volunteers, this year’s event was the largest ever.
In addition to individuals, nearly 500 teams participated, including 100 corporate teams from around the region that brought their employees together to build camaraderie in the walk/run, the rides, and through volunteering and fundraising.
Innovations in cancer research rely on philanthropic support, and Obliteride has raised more than $56 million over 12 years to propel discoveries at Fred Hutch. So far this year, more than 21,000 donors have contributed, and there’s still time to give. Fundraising continues through Sept. 30.
Thanks to Obliteride's 40+ sponsors and event supporters, 100% of participant-raised funds go directly to work advancing cancer research at Fred Hutch. Participants fundraise for the areas most meaningful to them — including specific disease areas, programs, researchers or clinicians. Every dollar matters.
For more inspiration, check out the visual storytelling below, and mark your calendar now for next year's Obliteride on Saturday, Aug. 9, 2025! We’d love to have you join us.